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Carbon nanotube-natural biopolymer nanovectors have important potential applications in delivery 
system for drugs and biomolecules. In this work, the use of multi-wall CNTs as nanoreserviors for drug 
loading and controlled release is demonstrated .We synthesized CNT-based Drug delivery systems; 
MWCNT-CS nanoparticles based on an ionotropic gelation method as a sustained-release systems for the 
delivery of Tenofovir (hydrophilic anti-retroviral drug).  
Molecularly imprinted polymer used as shell for encapsulating the synthesized polymer to reduce the 
toxicity of CNT and improved theit application in Drug Delivery System. The prepared nanoparticles were 
characterized by FTIR spectroscopy. TGA was applied to study the thermal stabilities, and SEM to investi-
gate the morphology.  
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1. INTRODUCTION 
 
The molecular imprinting technology can provide 
polymeric materials with the ability to recognize specif-
ic bioactive molecules with sorption and release behav-
ior that can be made sensitive to the properties of the 
surrounding medium. The potential advantage of im-
printed polymers capable of Drug Delivery System is 
the longer presence of the drug within body [1]. The 
molecular imprinting is a process to combine molecular 
template with functional monomers and form molecu-
larly imprinted polymers (MIPs) according to their in-
teractions that include both functional and shape com-
plementarity [2]. The cross-linking is added to make 
the polymer more stable. MIPs have not only chemical 
inertness and long-term stability, but also insolubility 
in water and most organic solvents [3]. 
Carbon nanotubes (CNTs) are one of the most ad-
vanced nano-vectors for highly efficient delivery of 
drugs and biomolecules owing to their large surface. 
Their very large surface area, allows multi-conjugation 
of various molecules on the side walls. The hydrophobi-
city of CNT limits their application in biology. It is 
highly desirable to modify CNT with different function-
al groups and incorporate other nanomaterials to cre-
ate new hybrid architectures to extend and optimize 
CNTs applications in these fields [4]. They have a larg-
er inner volume which allows more drug molecules to 
be encapsulated, and this volume is more easily acces-
sible because the end caps can be easily removed, and 
they have distinct inner and outer surfaces for func-
tionalization. They can be conjugated non-covalently or 
covalently with drugs, biomolecules and nanoparticles 
towards the development of a new-generation delivery 
system for drugs and biomolecules. 
CNTs are often oxidized to introduce carboxylic 
groups, followed by amidation, esterification or for-
mation of COO_NH3 salts. Thereafter, various hydro-
philic or hydrophobic molecules can be bound to CNT 
via amide or ester linkages. Polymers can also be graft-
ed to CNT by this method[5]. 
Introducing appropriate solubilization groups (such 
as – COOH, – OH and – NH2) either to the end or to 
the side wall of CNTs through chemical modification 
could overcome some solubility  problems. However, 
chemical modification would inevitably destroy electron 
conjugation system of CNTs, and then their inherent 
functionalities. Although acid treated CNT are water-
soluble, the carbonyl (C  O), carboxyl (– COOH), 
and/or hydroxyl (– OH) groups on their surfaces might 
lead to higher toxicity [6]. Thus, the functionalization of 
CNT with biopolymers promises to be one of the most 
successful methods to improve the hydrophilicity of 
CNT. These biopolymers can bring a hydrophilic sur-
face of the CNT for covalent, absorptive, or ionic bind-
ings with bioactive molecules. 
To maximize the therapeutic benefits of drug loaded 
nanoparticles they should be able to evade the reticulo-
endothelial system (RES). This can be done through the 
use of various surface coatings of  biodegradable hydro-
philic polymers [7]. 
Chitosan (CS) is a natural linear biopolyaminosac-
charide and its chemical modification is a valuable tool 
in the design of novel biocompatible materials, because 
the active amino and hydroxyl groups along its back-
bone allow great chemical flexibility. Recently, much 
attention has been paid to chitosan nanoparticles due 
to their advantageous such as biocompatible, biode-
gradable, non-toxic, hemostatic, anticancerogenic, etc. 
Hence, it is a widely opted candidate for investigating 
its medical applications such as drug delivery [8]. 
CNTs have a graphite structure containing conju-
gated double bonds some of which could be oxidized to 
form carboxylic acid groups on their surface during 
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purification by strong acids [9, 10]. These carboxylic 
acid groups that are formed mostly at the tube ends 
and at defects on the sidewalls [10] provide sites for 
reactions with amine or hydroxyl groups to form amide 
or ester linkages, respectively. Thus through formation 
of amide linkages between the reactive primary amine 
groups of chitosan and the carboxylic groups of the ac-
id-purified and oxidized CNTs, chitosan can be grafted 
onto CNTs. 
In this work, we synthesized CNT-CS NP-MIP as a 
sustained-release system for the delivery of Tenofovir 
(hydrophilic anti-retroviral drug).We used imprinted 
nanoparticle polymer for encapsulating of CNT-CS NPs. 
According to the Conference policy, the proceedings 
will be published instead of the abstract book. The con-
ference proceedings will be published up to the confer-
ence sessions for the convenience of the participants 
and the best dissemination through the Web, since the 
proceedings paper will be freely available on-line. In 
order to speed up the availability of your paper online, 
the submitted manuscript must be ready for publica-
tion. So, the strict requirements to the manuscript 
preparation exist. 
 
2. METHOD 
 
The MWCNTs were oxidized with mixture of  sulfu-
ric acid and nitric acid (v : v  3 : 1) to yield MWCNT-
COOH. The chitosan nanoparticles were obtained 
based on an ionotropic gelation interaction between 
positively charged chitosan and negatively charged 
TPP at room temperature. 
For The in situ synthesis of MWCNT-CS NP hy-
brids 50 mL of TPP aqueous solution (1 mg/ml) was 
dropwise added to 125 mL of 2 mg/mL CS in acetic acid 
solution(2 %, v/v) containing MWCNT with magnetic 
stirring at room temperature.The mixture was further 
stirred for 10 h. The MWCNT-CS NP hybrids obtained 
were purified by centrifugation (6,000 rpm, 30 min) and 
rinsed with water for future use. For drug adsorption, 
30 mg CNT-CS NP were incubated with 8 ml of 
200 ppm Tenofovir and stirred vigorously with a mag-
netic stirrer for 2 h at 37 °C. The nanoparticles were 
then centrifuged (6,000 rpm , 4 °C for 20 min) to re-
move any unabsorbed drugs.The molecular imprinted 
polymers shell for CNT-CS NP-Tenofovir were pre-
pared from a reagent mixture obtained by mixing of 
30 mg CNT-CS NP-Tenofovir and 4 mmol Methacrylic 
acid (MAA) in 5 ml Acetonitrile The solution was 
shaked in room temperature for 5 h to prearrange tem-
plate and monomer. 12 mmol TMPTA, 50 mg AIBN and 
30 ml acetonitrile were added to the solution The mix-
ture was degassed under vacuum in a sonicating water 
bath while being purged with nitrogen for a period of 
5 min. Maintaining a flow of nitrogen, the reaction 
flask was removed from the sonicating bath, sealed and 
placed inside a water bath at 60 °C to begin the reac-
tion. Under these conditions, the reaction was allowed 
to continue for 20 h. The produced polymer was centri-
fuged and washed with acetone and water. 
 
3. DISCUSSION 
 
CNT-CS NP-MIP nanoparticles were prepared by 
grafting method for anti-HIV drug delivery applications. 
The prepared CNT-CS-MIP nanoparticles were charac-
terized employing FTIR, SEM and TGA methods.
 
  
  
  
  
Fig. 1 – SEM results for a) CNT-COOH b) CS NPs  c) CNT-CS NPs and d) CNT-CS NP-MIP
a b 
c d 
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4. CONCLUSION 
 
The CNT-CS-MIP nanoparticles exhibited high dis-
persibility and long-term stability in diluted organic 
acids and the drug release could be effectively sus-
tained, indicating that the CNT-CS-MIP nanoparticles 
are accounted as a promising polymer nano-carrier sys-
tem for controlled delivery of anti-HIV and water-
soluble drugs. 
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